BackRepare Therapeutics Overview

Repare Therapeutics Profit Margin

Profitability ratio analysis for RPTX.

Quarterly Profit Margin

28.04%

As of Sep 2025

Annual Profit Margin (TTM)

173.53%
↑ 237.35% YoY

Trailing 12 months ending Sep 2025

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin